CONMED Corp. (CNMD)
49.26
-0.17
(-0.34%)
USD |
NYSE |
Sep 03, 16:00
49.26
0.00 (0.00%)
After-Hours: 20:00
CONMED Research and Development Expense (Annual) : 55.88M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 55.88M |
| December 31, 2024 | 54.43M |
| December 31, 2023 | 52.60M |
| December 31, 2022 | 47.15M |
| December 31, 2021 | 43.56M |
| December 31, 2020 | 40.47M |
| December 31, 2019 | 45.46M |
| December 31, 2018 | 28.48M |
| December 31, 2017 | 32.31M |
| December 31, 2016 | 32.25M |
| December 31, 2015 | 27.44M |
| December 31, 2014 | 27.78M |
| December 31, 2013 | 25.83M |
| December 31, 2012 | 28.21M |
| December 31, 2011 | 28.65M |
| December 31, 2010 | 29.65M |
| December 31, 2009 | 31.84M |
| December 31, 2008 | 33.11M |
| Date | Value |
|---|---|
| December 31, 2007 | 30.40M |
| December 31, 2006 | 30.72M |
| December 31, 2005 | 25.47M |
| December 31, 2004 | 20.20M |
| December 31, 2003 | 17.31M |
| December 31, 2002 | 16.09M |
| December 31, 2001 | 14.83M |
| December 31, 2000 | 14.87M |
| December 31, 1999 | 12.11M |
| December 31, 1998 | 12.03M |
| December 31, 1997 | 3.037M |
| December 31, 1996 | 2.953M |
| December 31, 1995 | 2.832M |
| December 31, 1994 | 2.352M |
| December 31, 1993 | 2.222M |
| December 31, 1992 | 1.695M |
| December 31, 1991 | 1.275M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Stryker Corp. | 1.567B |
| Alphatec Holdings, Inc. | 76.27M |
| Baxter International, Inc. | 503.00M |
| Becton, Dickinson & Co. | 1.265B |